Literature DB >> 10895408

Value of the initial electrocardiogram in patients with inferior-wall acute myocardial infarction for prediction of multivessel coronary artery disease.

A Mager1, S Sclarovsky, I Herz, Y Adler, B Strasberg, Y Birnbaum.   

Abstract

BACKGROUND: Patients with inferior-wall acute myocardial infarction (AMI) who have ST-segment depression in the left precordial leads (LSTD+) on the initial electrocardiogram were reported to have more diffuse coronary artery disease (CAD) than had those without this finding (LSTD-). This suggests that LSTD+ patients may need extensive revascularization interventions more often than do LSTD- patients. However, this has not yet been confirmed.
OBJECTIVE: To compare the coronary angiographic findings and treatment strategies for patients with inferior-wall AMI according to the LSTD pattern.
METHODS: The clinical outcomes and the angiographic findings for 238 consecutive patients aged < or = 75 years who had been admitted to our hospital between 1 February 1995 and 1 February 1997 with inferior-wall AMI were retrospectively analyzed. The patients were divided into two groups according to the pattern of precordial ST-segment depression: LSTD+, ST-segment depression in leads V4-V6; and LSTD-, absence of this finding. All patients were treated according to current practice guidelines including with thrombolysis and revascularization interventions.
RESULTS: The final study population included 217 patients; 83 were LSTD+ and 134 were LSTD-. All underwent coronary angiography within 30 days of the infarction. Compared with LSTD- patients, LSTD+ patients tended to be older (mean age 62.7 +/- 11.7 versus 58.3 +/- 9.6 years, P = 0.004), and had higher incidences of hypertension (39.8 versus 24.6%, P = 0.019) previous myocardial infarction (45.8 versus 20.1%, P = 0.0001) and congestive heart failure (21.7 versus 3.7%, P = 0.00008). Three-vessel CAD was much more common, and single-vessel CAD much less common, in the LSTD+ than in LSTD- group (62.7 versus 13.4% and 8.4 versus 50.7%, P < 0.00001 for both). Coronary-artery-bypass surgery and multivessel percutaneous coronary interventions (PCI) were used in treating 65.1% of the LSTD+ versus only 6.0% of the LSTD- patients (P < 0.00001), whereas single-vessel PCI was used in treating 71.6% of the LSTD- patients versus only 24.1% of the LSTD+ patients (P < 0.00001). Thus, the LSTD- pattern predicted single-vessel disease and single-vessel PCI only, whereas the LSTD+ pattern was predictive of multivessel CAD and of use of coronary-artery-bypass surgery or multivessel PCI (predictive values of 94.0 and 65.1%, respectively).
CONCLUSIONS: Among patients with inferior-wall AMI, left precordial ST-segment depression predicts a very high prevalence of multivessel CAD and use of extensive revascularization interventions. The absence of this finding predicts nondiffuse CAD and lack of a need for extensive revascularization.

Entities:  

Mesh:

Year:  2000        PMID: 10895408     DOI: 10.1097/00019501-200007000-00006

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  3 in total

Review 1.  The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis.

Authors:  Y Birnbaum; B J Drew
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

Review 2.  Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?

Authors:  Yochai Birnbaum; Glenn N Levine; John French; Juan Carlos Kaski; Dan Atar; Mahboob Alam; David Hasdai; Hani Jneid; Barry F Uretsky
Journal:  Cardiovasc Drugs Ther       Date:  2020-07-15       Impact factor: 3.727

3.  ST-segment depression in left precordial leads in electrocardiogram of patients with acute inferior myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Hossein Namdar; Leyla Imani; Samad Ghaffari; Naser Aslanabadi; Najmeh Reshadati; Zhila Samani; Ghiti Davarmoin; Naser Moayyednia; Yalda Nazer; Shahla Sarhangzadeh; Ahmad Separham
Journal:  Interv Med Appl Sci       Date:  2018-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.